Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG™ Test

Truvian Sciences today announced that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s Easy Check COVID-19 IgM/IgGTM antibody test. Truvian’s Easy Check test is being produced at mass scale at a US based manufacturing facility and will be available to healthcare practitioners immediately.